Tag Archives: KPTI

Leerink Partners Remains a Buy on Karyopharm Therapeutics (KPTI)

In a report released today, Jonathan Chang from Leerink Partners maintained a Buy rating on Karyopharm Therapeutics (KPTI – Research Report), with a price target of $29.00. The company’s shares closed last Tuesday at $19.63. According to TipRanks.com, Chang is

Saturday’s Midday Stock Update: Chesapeake Energy (CHK), Continental Resources (CLR), Karyopharm Therapeutics (KPTI), Apache (APA), Weyerhaeuser (WY)

So far Saturday, May 2, NASDAQ is down -2.05% and the S&P is down -2.52%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Chesapeake Energy (CHK – Research Report), Continental Resources (CLR –

RBC Capital Sticks to Their Buy Rating for Karyopharm Therapeutics (KPTI)

RBC Capital analyst Brian Abrahams maintained a Buy rating on Karyopharm Therapeutics (KPTI – Research Report) today and set a price target of $34.00. The company’s shares closed last Thursday at $20.53. According to TipRanks.com, Abrahams is a 5-star analyst

A Director at Karyopharm Therapeutics is Exercising Options

Yesterday it was reported that a Director at Karyopharm Therapeutics (KPTI – Research Report), Barry Greene, exercised options to buy 3,030 KPTI shares at $0.03 a share, for a total transaction value of $90. Following this transaction Barry Greene’s holding

Tuesday’s Midday Movers: Omeros (OMER), Zogenix (ZGNX), Cytokinetics (CYTK), Karyopharm Therapeutics (KPTI), Invivo Therapeutics Holdings (NVIV)

So far Tuesday, March 3, NASDAQ is down -2.41% and the S&P is down -3.08%. Here are this morning’s most active stocks: Omeros (OMER – Research Report), Zogenix (ZGNX – Research Report), Cytokinetics (CYTK – Research Report), Karyopharm Therapeutics (KPTI

Karyopharm Therapeutics (KPTI) Gets a Buy Rating from Canaccord Genuity

Canaccord Genuity analyst Arlinda Lee reiterated a Buy rating on Karyopharm Therapeutics (KPTI – Research Report) yesterday and set a price target of $35.00. The company’s shares closed last Monday at $27.72, close to its 52-week high of $29.61. According